Improvement programs may lead to improved Chlamydia trachomatis testing

Article

The Centers for Disease Control and Prevention (CDC) recommends using nucleic-acid amplification tests (NAAT) when testing female patients under the age of 25 for Chlamydia trachomatis.

Although the Centers for Disease Control and Prevention (CDC) recommends using nucleic-acid amplification tests (NAAT), many clinicians still use urine NAAT to test for Chlamydia trachomatis in sexually active female patients under the age of 25.

A new report explored whether an improvement program could be beneficial in increasing the number of clinicians using the vaginal swab NAAT. The study ultimately discovered that the quality improvement program did, in fact, lead to significant increase in the use of vaginal swabs to test for C. trachomatis.

For details on this study and its findings, visit Contemporary Pediatrics.

Related Videos
Why doxycycline PEP lacks clinical data for STI prevention in women
Understanding the impact of STIs on young adults | Image Credit: providers.ucsd.edu.
Deciding the best treatment for uterine fibroids | Image Credit: jeffersonhealth.org.
How to address sexual dysfunction during menopause | Image Credit: health.usnews.com
What's new in endometrium care? | Image Credit: nyulangone.org
New algorithm to identify benign lesions developed | Image Credit: nemours.mediaroom.com
Discussing PCOS: misconceptions, management, encouragement | Image Credit: ahn.org
Related Content
© 2024 MJH Life Sciences

All rights reserved.